About David Neustaedter
Form D filings for R3 Vascular in 2024 list David Neustaedter as director.
David Neustaedter first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name David Neustaedter in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people David Neustaedter works with at each company, as listed on that company's latest Form D.
R3 Vascular Inc. · Form D, Sep 12, 2024
KR
Kamal Ramzipoor
CTO, Founder
FG
Frederik Groenewegen
Director
JS
John Springer
Director
MH
Michael Hurley
Director
CO
Christopher Owens
President and Chief Executive Officer, director
Amir Abolfathi
Director
NH
Nathan Harrington
Director